ACRS Aclaris Therapeutics, Inc. - Common Stock
$4,57
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 7, 2026
Zakres 52 tyg.
$1–$5
85% of range
Ocena Analityków
STRONG BUY
16 analysts
Cena Docelowa
$10
+112% upside
P/E (TTM)
-5.7
ROE
-55.3%
Marża Zysku Netto
-829.6%
ACRS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$4.57
Kapitalizacja Rynkowa
$363M
P/E (TTM)
-5.7
EPS (TTM)
$-0.53
Przychody (TTM)
$8M
Stopa dywidendy
—
ROE
-55.3%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$1 – $5
ACRS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$8M
2017-12-31
→
2025-12-31
EPS
$-0.53
2019-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-47M
2016-12-31
→
2025-12-31
Marże
-829.6%
2017-12-31
→
2018-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
ACRS
Mediana porównawcza
P/E (TTM)
-5.7
42.1
P/S (TTM)
46.3
11.8
P/B
3.5
3.4
Price / FCF (Cena / FCF)
-7.7
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
ACRS
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-975.9%
—
Net Profit Margin (Marża Zysku Netto)
-829.6%
-5.7%
ROA
-34.1%
-5.4%
ROE
-55.3%
-23.4%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
ACRS
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
3.4
4.0
Quick Ratio (Wskaźnik Szybkości)
0.7
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
ACRS
Mediana porównawcza
Revenue YoY (Przychody R/R)
-58.2%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-35.9%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
3.8%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
ACRS
Mediana porównawcza
ACRS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
16 analityków
- Mocne kupno 7 43,8%
- Kup 7 43,8%
- Trzymaj 2 12,5%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
9 analityków · 2026-05-17
Mediana
$10.00
Teraz
$4.57
Niski
$4.00
Wysoki
$16.00
Średni cel
$10.00
+118,8%
Średnia cel
$9.67
+111,5%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.01%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.15 | $-0.16 | 0.01% |
| 31 grudnia 2025 | $-0.16 | $-0.15 | -0.01% |
| 30 września 2025 | $-0.12 | $-0.14 | 0.02% |
| 30 czerwca 2025 | $-0.13 | $-0.14 | 0.01% |
| 31 marca 2025 | $-0.12 | $-0.12 | -0.00% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | — |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| BIOA | $495M | -5.9 | — | -896.1% | -28.4% | — |
| SGP | — | — | — | — | 50.0% | — |
| ANRO | $568M | -8.1 | — | — | -46.1% | — |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | — |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | $19M | $31M | $30M | $7M | $6M | $4M | $6M | $2M | |
| Cost of Revenue | $2M | $3M | $3M | $4M | $5M | $5M | $4M | $4M | $1M | |
| Gross Profit | · | · | · | · | · | · | · | $3M | $476.0K | |
| R&D Expense | $53M | $34M | $98M | $78M | $44M | $29M | $64M | $61M | $36M | |
| SG&A Expense | $22M | $22M | $32M | $25M | $24M | $21M | $28M | $26M | $19M | |
| Operating Expenses | $84M | $161M | $129M | $120M | $96M | $57M | $115M | $91M | $56M | |
| Operating Income | $-76M | $-142M | $-97M | $-90M | $-90M | $-51M | $-111M | $-85M | $-54M | |
| Interest Income | $8M | $8M | $9M | · | · | · | · | · | · | |
| Other Non-op | $11M | $10M | $9M | $3M | $-1M | $-424.0K | $-2M | $3M | $2M | |
| Pretax Income | $-65M | $-132M | $-89M | $-87M | $-91M | $-51M | $-114M | $-82M | $-70M | |
| Income Tax | · | · | $-367.0K | · | · | $-182.0K | · | · | $-2M | |
| Net Income | $-65M | $-132M | $-88M | $-87M | $-91M | $-51M | $-161M | $-133M | $-69M | |
| EPS (Basic) | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 | $-1.20 | $-3.90 | · | · | |
| EPS (Diluted) | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 | $-1.20 | $-3.90 | · | · | |
| Shares (Basic) | 122,564,741 | 77,296,665 | 69,808,855 | 65,213,944 | 56,730,583 | 42,539,293 | 41,323,921 | · | · | |
| Shares (Diluted) | 122,564,741 | 77,296,665 | 69,808,855 | 65,213,944 | 56,730,583 | 42,539,293 | 41,323,921 | · | · | |
| EBITDA | $-76M | $-141M | $-96M | $-89M | $-89M | $-50M | $-105M | $-134M | $-72M |
Bilans 27
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $25M | $40M | $45M | $27M | $22M | $34M | $168M | $20M | |
| Receivables | · | $318.0K | $298.0K | $484.0K | $623.0K | $772.0K | $704.0K | $563.0K | $481.0K | |
| Inventory | · | · | · | · | · | · | $0 | $791.0K | · | |
| Prepaid Expense | · | $12M | $9M | $13M | $13M | $3M | $3M | $5M | $6M | |
| Current Assets | $96M | $126M | $129M | $232M | $205M | $57M | $84M | $179M | $200M | |
| PP&E (Net) | $761.0K | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | · | $6M | $6M | $5M | $5M | $4M | $5M | $4M | $3M | |
| Accum. Depreciation | · | $5M | $4M | $4M | $3M | $3M | $2M | $1M | $480.0K | |
| Goodwill | · | · | · | · | · | · | · | $19M | $19M | |
| Intangibles | · | · | $269.0K | $7M | $7M | $7M | $7M | $7M | $7M | |
| Other Non-current Assets | $3M | $3M | $4M | $3M | $4M | $5M | $5M | $332.0K | $279.0K | |
| Total Assets | $160M | $220M | $197M | $255M | $251M | $71M | $98M | $276M | $244M | |
| Accounts Payable | $13M | $5M | $9M | $10M | $10M | $5M | $10M | $12M | $8M | |
| Accrued Liabilities | $9M | $20M | $19M | $9M | $10M | $6M | $8M | $8M | $5M | |
| Current Liabilities | $29M | $32M | $31M | $22M | $23M | $15M | $22M | $27M | $13M | |
| Capital Leases | $2M | $2M | $3M | $2M | $2M | $3M | $4M | · | · | |
| Deferred Tax | · | · | · | $367.0K | $367.0K | $367.0K | $549.0K | $549.0K | $549.0K | |
| Other Non-current Liabilities | $2M | $4M | $3M | $2M | $2M | $3M | $4M | $476.0K | $558.0K | |
| Total Liabilities | $57M | $65M | $40M | $57M | $54M | $33M | $28M | $60M | $18M | |
| Long-term Debt | · | · | · | · | · | $11M | · | $30M | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | · | · | |
| Paid-in Capital | $1.07B | $1.06B | $928M | $881M | $793M | $542M | $524M | $507M | $385M | |
| Retained Earnings | $-968M | $-903M | $-771M | $-682M | $-595M | $-505M | $-454M | $-292M | $-159M | |
| AOCI | $610.0K | $97.0K | $-106.0K | $-897.0K | $-224.0K | $-94.0K | $-66.0K | $-69.0K | $-246.0K | |
| Stockholders' Equity | $103M | $156M | $157M | $198M | $197M | $38M | $70M | $215M | $225M | |
| Liabilities + Equity | $160M | $220M | $197M | $255M | $251M | $71M | $98M | $276M | $244M | |
| Shares Outstanding | 120,499,433 | 107,850,124 | 70,894,889 | 66,688,647 | 61,228,446 | 45,109,314 | 41,485,638 | 41,210,725 | 30,856,505 |
Przepływy pieniężne 11
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $454.0K | $807.0K | $863.0K | $797.0K | $923.0K | $1M | $6M | $2M | $402.0K | |
| Stock-based Comp | $12M | $11M | $21M | $15M | $14M | $11M | $16M | $20M | $14M | |
| Amort. of Intangibles | · | · | $75.0K | $75.0K | $75.0K | $75.0K | $75.0K | $75.0K | $31.0K | |
| Restructuring | · | · | $3M | · | · | · | · | · | · | |
| Other Non-cash | $5M | $100M | $-11M | $4M | $24M | $-149.0K | $42M | $10M | $-972.0K | |
| Operating Cash Flow | $-47M | $-20M | $-78M | $-68M | $-52M | $-39M | $-96M | $-101M | $-55M | |
| CapEx | $111.0K | $121.0K | $1M | $605.0K | $308.0K | $453.0K | $2M | $1M | $1M | |
| Investing Cash Flow | $48M | $-70M | $46M | $13M | $-168M | $6M | $106M | $9M | $-56M | |
| Financing Cash Flow | $-6M | $75M | $27M | $73M | $225M | $18M | $-30M | $128M | $100M | |
| Net Change in Cash | $-5M | $-15M | $-5M | $18M | $5M | $-14M | $-21M | $37M | $-10M | |
| Free Cash Flow | $-47M | $-20M | $-80M | $-68M | $-52M | $-39M | $-98M | $-102M | $-56M |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 32.1% | 28.3% | |
| Operating Margin | -975.9% | -758.2% | -311.6% | -302.0% | -1327.1% | -785.4% | -2627.3% | -1341.9% | -4303.2% | |
| Net Margin | -829.6% | -705.5% | -283.2% | -292.1% | -1344.0% | -787.0% | -3817.2% | -1315.4% | -4071.5% | |
| Pretax Margin | -829.6% | -705.5% | -284.3% | -292.1% | -1344.0% | -792.0% | -3817.2% | -1315.4% | -4180.2% | |
| EBITDA Margin | -970.1% | -753.9% | -308.8% | -299.3% | -1313.4% | -765.0% | -2475.7% | -1323.3% | -4279.3% | |
| ROA | -34.1% | -63.2% | -39.1% | -34.4% | -56.4% | -60.3% | -86.3% | -51.1% | -32.7% | |
| ROE | -55.3% | -92.5% | -56.5% | -41.6% | -43.9% | -130.1% | -207.9% | -73.5% | -34.7% | |
| ROIC | · | · | -61.7% | · | · | -134.8% | · | · | -31.3% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 4.0 | 4.2 | 10.6 | 8.9 | 3.9 | 3.7 | 6.6 | 15.7 | |
| Quick Ratio | 0.7 | 0.8 | 1.3 | 2.1 | 1.2 | 1.5 | 3.4 | 6.3 | 1.6 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | 10.3 | 17.3 | · | |
| Receivables Turnover | · | 60.8 | 79.9 | 53.8 | 9.7 | 8.8 | 6.7 | 3.8 | 7.0 |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -58.2% | -40.1% | 5.0% | 340.1% | 4.3% | · | · | · | · | |
| Revenue CAGR 3Y | -35.9% | 40.4% | 68.9% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $19M | $31M | $30M | $7M | $6M | $4M | $6M | $2M | |
| Net Income TTM | $-65M | $-132M | $-88M | $-87M | $-91M | $-51M | $-161M | $-133M | $-69M | |
| Market Cap | $363M | $267M | $74M | $1.05B | $890M | $292M | $78M | $305M | $760M | |
| P/E | -5.7 | -1.5 | -0.8 | -11.8 | -9.1 | -5.4 | -0.5 | · | · | |
| P/S | 46.3 | 14.3 | 2.4 | 35.3 | 131.7 | 45.0 | 18.5 | 49.5 | 451.8 | |
| P/B | 3.5 | 1.7 | 0.5 | 5.3 | 4.5 | 7.8 | 1.1 | 1.4 | 3.4 | |
| P / Tangible Book | 3.5 | 1.7 | 0.5 | 5.5 | 4.7 | 9.6 | · | · | · | |
| P / Cash Flow | -7.7 | -13.3 | -1.0 | -15.5 | -17.1 | -7.6 | -0.8 | -3.0 | -13.9 | |
| P / FCF | -7.7 | -13.2 | -0.9 | -15.4 | -17.0 | -7.5 | -0.8 | -3.0 | -13.6 | |
| Earnings Yield | -17.6% | -69.0% | -121.0% | -8.4% | -11.0% | -18.6% | -206.3% | · | · |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $1M | $3M | $2M | $1M | $9M | $4M | $3M | $2M | $18M | $9M | $2M | $3M | $8M | $19M | $2M | |
| Cost of Revenue | $395.0K | $532.0K | $538.0K | $515.0K | $506.0K | $705.0K | $654.0K | $624.0K | $809.0K | $725.0K | $848.0K | $1M | $808.0K | $877.0K | $923.0K | $1M | |
| R&D Expense | $16M | $17M | $13M | $11M | $12M | $9M | $6M | $9M | $10M | $27M | $24M | $25M | $23M | $21M | $24M | $19M | |
| SG&A Expense | $7M | $6M | $5M | $5M | $6M | $5M | $6M | $5M | $7M | $8M | $7M | $8M | $9M | $7M | $6M | $6M | |
| Operating Expenses | $24M | $24M | $20M | $20M | $20M | $109M | $15M | $16M | $21M | $22M | $41M | $34M | $32M | $37M | $40M | $23M | |
| Operating Income | $-22M | $-23M | $-17M | $-18M | $-18M | $-100M | $-10M | $-13M | $-19M | $-4M | $-32M | $-32M | $-30M | $-29M | $-21M | $-21M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | · | · | |
| Other Non-op | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $922.0K | $462.0K | |
| Pretax Income | · | $-20M | $-15M | $-15M | $-15M | $-97M | $-8M | $-11M | $-17M | · | · | · | · | · | · | · | |
| Net Income | $-20M | $-20M | $-15M | $-15M | $-15M | $-97M | $-8M | $-11M | $-17M | $-1M | $-29M | $-30M | $-28M | $-28M | $-20M | $-21M | |
| EPS (Basic) | $-0.15 | $-0.16 | $-0.12 | $-0.13 | $-0.12 | $-1.21 | $-0.11 | $-0.15 | $-0.24 | $-0.02 | $-0.41 | $-0.42 | $-0.42 | $-0.41 | $-0.30 | $-0.31 | |
| EPS (Diluted) | $-0.15 | $-0.16 | $-0.12 | $-0.13 | $-0.12 | $-1.21 | $-0.11 | $-0.15 | $-0.24 | $-0.02 | $-0.41 | $-0.42 | $-0.42 | $-0.41 | $-0.30 | $-0.31 | |
| Shares (Basic) | 128,810,050 | -245,025,840 | 122,619,311 | 122,580,967 | 122,390,303 | -136,451,324 | 71,381,731 | 71,291,400 | 71,074,858 | -138,505,385 | 70,807,934 | 70,633,528 | 66,872,778 | -128,882,450 | 66,675,337 | 65,990,031 | |
| Shares (Diluted) | 128,810,050 | -245,025,840 | 122,619,311 | 122,580,967 | 122,390,303 | -136,451,324 | 71,381,731 | 71,291,400 | 71,074,858 | -138,505,385 | 70,807,934 | 70,633,528 | 66,872,778 | -128,882,450 | 66,675,337 | 65,990,031 | |
| EBITDA | $-22M | · | $-17M | $-18M | $-18M | · | $-10M | $-13M | $-19M | · | $-32M | $-32M | $-30M | · | $-21M | $-21M |
Bilans 24
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $20M | $25M | $25M | $30M | $25M | $48M | $23M | $36M | $40M | $39M | $31M | $45M | $45M | $62M | $68M | |
| Receivables | · | · | · | $194.0K | $250.0K | · | $343.0K | $325.0K | $373.0K | $298.0K | $346.0K | $431.0K | $686.0K | $484.0K | $597.0K | $637.0K | |
| Prepaid Expense | · | · | · | $4M | $3M | · | $4M | $6M | $7M | $9M | $20M | $13M | $13M | $13M | $8M | $10M | |
| Current Assets | $110M | $96M | $101M | $104M | $109M | $126M | $132M | $118M | $135M | $129M | $123M | $133M | $184M | $232M | $257M | $259M | |
| PP&E (Net) | $750.0K | $761.0K | $811.0K | $868.0K | $942.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| PP&E (Gross) | · | · | $6M | $6M | $6M | · | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | |
| Accum. Depreciation | · | · | $5M | $5M | $5M | · | $5M | $5M | $4M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $7M | $7M | $7M | $7M | $7M | $7M | |
| Other Non-current Assets | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Total Assets | $199M | $160M | $176M | $189M | $198M | $220M | $182M | $161M | $174M | $197M | $218M | $236M | $230M | $255M | $268M | $278M | |
| Accounts Payable | $15M | $13M | $9M | $9M | $6M | $5M | $8M | $7M | $11M | $9M | $10M | $11M | $8M | $10M | $8M | $6M | |
| Accrued Liabilities | $6M | $9M | $10M | $11M | $9M | $20M | $5M | $6M | $7M | $19M | $15M | $9M | $7M | $9M | $9M | $8M | |
| Current Liabilities | $27M | $29M | $26M | $27M | $22M | $32M | $19M | $16M | $20M | $31M | $27M | $23M | $18M | $22M | $20M | $16M | |
| Capital Leases | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $367.0K | $367.0K | $367.0K | $367.0K | $367.0K | $367.0K | |
| Other Non-current Liabilities | $1M | $2M | $2M | $2M | $4M | $4M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $55M | $57M | $55M | $57M | $54M | $65M | $52M | $27M | $32M | $40M | $62M | $56M | $53M | $57M | $48M | $42M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $1.13B | $1.07B | $1.07B | $1.06B | $1.06B | $1.06B | $936M | $933M | $930M | $928M | $927M | $921M | $888M | $881M | $876M | $872M | |
| Retained Earnings | $-988M | $-968M | $-948M | $-933M | $-918M | $-903M | $-806M | $-799M | $-788M | $-771M | $-769M | $-740M | $-710M | $-682M | $-655M | $-635M | |
| AOCI | $22.0K | $610.0K | $597.0K | $482.0K | $434.0K | $97.0K | $427.0K | $-463.0K | $-364.0K | $-106.0K | $-1M | $-1M | $-354.0K | $-897.0K | $-1M | $-1M | |
| Stockholders' Equity | $144M | $103M | $120M | $132M | $144M | $156M | $130M | $134M | $142M | $157M | $156M | $180M | $177M | $198M | $220M | $236M | |
| Liabilities + Equity | $199M | $160M | $176M | $189M | $198M | $220M | $182M | $161M | $174M | $197M | $218M | $236M | $230M | $255M | $268M | $278M | |
| Shares Outstanding | 139,652,849 | 120,499,433 | 108,342,592 | 108,328,794 | 108,265,529 | 107,850,124 | 71,417,513 | 71,332,825 | 71,248,017 | 70,894,889 | 70,818,954 | 70,769,702 | 67,206,025 | 66,688,647 | 66,679,641 | 66,667,580 |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $102.0K | $102.0K | $110.0K | $114.0K | $128.0K | $143.0K | $179.0K | $242.0K | $243.0K | $228.0K | $219.0K | $218.0K | $198.0K | $190.0K | $193.0K | $206.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $2M | $1M | $6M | $7M | $7M | $5M | $4M | $4M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $19.0K | $19.0K | $19.0K | $18.0K | $19.0K | $19.0K | |
| Restructuring | · | · | · | · | · | · | $32.0K | $98.0K | $3M | · | · | · | · | · | · | · | |
| Other Non-cash | $-2M | · | · | · | $-2M | · | · | · | $-6M | · | · | · | $-5M | · | · | · | |
| Operating Cash Flow | $-18M | $-13M | $-11M | $-10M | $-13M | $-9M | $22M | $-12M | $-21M | $-7M | $-25M | $-21M | $-26M | $-19M | $-8M | $-20M | |
| CapEx | $13.0K | $24.0K | $23.0K | $21.0K | $43.0K | $0 | $0 | $-14.0K | $135.0K | $441.0K | $84.0K | $231.0K | $553.0K | $105.0K | $150.0K | $186.0K | |
| Investing Cash Flow | $-31M | $10M | $14M | $5M | $19M | $-89M | $3M | $-674.0K | $17M | $8M | $33M | $-20M | $26M | $3M | $1M | $-21M | |
| Financing Cash Flow | $58M | $-3M | $-3M | $-9.0K | $-275.0K | $75M | $22.0K | $-11.0K | $-55.0K | $49.0K | $-87.0K | · | · | $37.0K | $-11.0K | $73M | |
| Net Change in Cash | $9M | $-5M | $-146.0K | $-5M | $6M | $-23M | $25M | $-13M | $-4M | $838.0K | $8M | $-14M | $-555.0K | $-16M | $-7M | $32M | |
| Free Cash Flow | $-18M | · | · | · | $-13M | · | · | · | $-21M | · | · | · | $-27M | · | · | · |
Rentowność 6
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1111.8% | · | -519.8% | -1035.9% | -1242.9% | · | -240.9% | -464.7% | -789.4% | · | -340.2% | -1702.2% | -1183.5% | · | -109.8% | -1374.0% | |
| Net Margin | -993.2% | · | -443.0% | -868.3% | -1036.8% | · | -174.6% | -397.2% | -706.5% | · | -315.2% | -1582.1% | -1113.9% | · | -104.9% | -1343.7% | |
| Pretax Margin | · | · | -443.0% | -868.3% | -1036.8% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1106.7% | · | -519.8% | -1035.9% | -1234.1% | · | -240.9% | -464.7% | -779.3% | · | -340.2% | -1702.2% | -1175.6% | · | -109.8% | -1374.0% | |
| ROA | -10.0% | · | -8.2% | -8.8% | -8.1% | · | -3.8% | -5.5% | -8.4% | · | -12.0% | -11.5% | -12.3% | · | -7.5% | -7.2% | |
| ROE | -13.8% | · | -11.7% | -11.6% | -10.5% | · | -5.3% | -7.0% | -10.6% | · | -15.6% | -14.2% | -15.8% | · | -9.1% | -8.8% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.0 | · | 3.9 | 3.9 | 5.1 | · | 7.0 | 7.5 | 6.7 | · | 4.5 | 5.8 | 10.1 | · | 13.0 | 16.0 | |
| Quick Ratio | 1.0 | · | 1.0 | 1.0 | 1.4 | · | 2.6 | 1.5 | 1.8 | · | 1.4 | 1.4 | 2.5 | · | 3.1 | 4.2 |
Efektywność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | |
| Receivables Turnover | · | · | · | 6.8 | 4.7 | · | 12.6 | 7.3 | 4.5 | · | 19.7 | 3.5 | 3.8 | · | 27.0 | 1.9 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | · | $11M | $10M | $11M | · | $19M | $16M | $16M | · | $33M | $25M | $25M | · | $24M | $6M | |
| Net Income TTM | $-65M | · | $-53M | $-49M | $-51M | · | $-65M | $-87M | $-104M | · | $-107M | $-98M | $-87M | · | $-80M | $-79M | |
| Market Cap | $524M | · | $206M | $154M | $166M | · | $82M | $78M | $88M | · | $485M | $734M | $544M | · | $1.05B | $931M | |
| P/E | -7.2 | · | -4.0 | -2.8 | -2.5 | · | -1.3 | -0.9 | -0.8 | · | -4.4 | -7.2 | -6.0 | · | -12.4 | -10.7 | |
| P/S | 61.4 | · | 18.9 | 14.9 | 15.1 | · | 4.4 | 4.8 | 5.5 | · | 14.8 | 29.4 | 22.2 | · | 44.4 | 144.0 | |
| P/B | 3.6 | · | 1.7 | 1.2 | 1.1 | · | 0.6 | 0.6 | 0.6 | · | 3.1 | 4.1 | 3.1 | · | 4.8 | 3.9 | |
| P / Tangible Book | 3.6 | · | 1.7 | 1.2 | 1.1 | · | 0.6 | 0.6 | 0.6 | · | 3.2 | 4.2 | 3.2 | · | 4.9 | 4.1 | |
| P / Cash Flow | -28.9 | · | · | · | -12.7 | · | · | · | -4.2 | · | · | · | -20.6 | · | · | · | |
| P / FCF | -28.8 | · | · | · | -12.6 | · | · | · | -4.2 | · | · | · | -20.2 | · | · | · | |
| Earnings Yield | -13.9% | · | -25.3% | -35.9% | -40.5% | · | -79.1% | -110.9% | -120.2% | · | -22.6% | -14.0% | -16.6% | · | -8.1% | -9.4% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $8M | $19M | $31M | $30M | $7M |
| Marża Operacyjna % | -975.9% | -758.2% | -311.6% | -302.0% | -1327.1% |
| Zysk netto | $-65M | $-132M | $-88M | $-87M | $-91M |
| Rozwodniony EPS | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 3.4 | 4.0 | 4.2 | 10.6 | 8.9 |
| Wskaźnik Szybkości | 0.7 | 0.8 | 1.3 | 2.1 | 1.2 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-47M | $-20M | $-80M | $-68M | $-52M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.